Hyun Cheol Chung

15PUBLICATIONS
45CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Discourse and pragmaticsMolecular targetsPredictive and prognostic markersGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Jul 20, 2024
Lenvatinib plus pembrolizumab for patients with previously treated, advanced, triple-negative breast cancer: Results from the triple-negative breast cancer cohort of the phase 2 LEAP-005 Study.

Hyun Cheol Chung, Esma Saada-Bouzid, Federico Longo

|Mar 04, 2024
Reply to B. Freidlin et al.

Choong-Kun Lee, Sejung Park, Chung Mo Nam

|Oct 26, 2023
Open-Label, Multicenter, Randomized, Biomarker-Integrated Umbrella Trial for Second-Line Treatment of Advanced Gastric Cancer: K-Umbrella Gastric Cancer Study.

Choong-Kun Lee, Hyo Song Kim, Minkyu Jung

|Aug 27, 2023
Monitoring the Outcomes of Systemic Chemotherapy Including Immune Checkpoint Inhibitor for HER2-Positive Metastatic Gastric Cancer by Liquid Biopsy.

Seung-Hyun Jung, Choong-Kun Lee, Woo Sun Kwon

|Jun 26, 2023
Trastuzumab Combined With Ramucirumab and Paclitaxel in Patients With Previously Treated Human Epidermal Growth Factor Receptor 2-Positive Advanced Gastric or Gastroesophageal Junction Cancer.

Chang Gon Kim, Minkyu Jung, Hyo Song Kim

|Feb 08, 2023
Breakthroughs in the Systemic Treatment of HER2-Positive Advanced/Metastatic Gastric Cancer: From Singlet Chemotherapy to Triple Combination.

Sun Young Rha, Hyun Cheol Chung

Pageof 3

Frequent Collaborators

7 joint publications

Sun Young Rha

5 joint publications

Choong-Kun Lee

3 joint publications

Hyo Song Kim

3 joint publications

Sejung Park